Supreme Court Temporarily Restores Mail-Order Access to Abortion Pill Mifepristone
The U.S. Supreme Court has temporarily reinstated the ability to obtain the abortion pill mifepristone via mail, pausing a lower court's restriction while further legal proceedings are considered.
On May 4, 2026, the U.S. Supreme Court issued an order temporarily reinstating mail-order access to the abortion pill mifepristone. Justice Samuel Alito's decision pauses a recent ruling by the 5th U.S. Circuit Court of Appeals that had imposed restrictions requiring in-person distribution of the drug.
The Supreme Court's intervention came in response to emergency appeals from pharmaceutical companies Danco Laboratories and GenBioPro, who argued for restored access. The temporary stay is set to last until May 11, allowing time for further legal deliberations.
Mifepristone, approved by the FDA in 2000, is commonly used alongside misoprostol for early-stage abortions. The availability of these medications has been crucial in maintaining abortion access, especially in states with restrictive laws.
The legal challenge, initiated by Louisiana, questions the FDA's regulations and the drug's safety, despite its longstanding approval. The outcome of this case could have significant implications for abortion access nationwide.